Scala Biodesign

Computerized image of an artificial intelligence robot with a data panel in the background
Scala Biodesign launches with $5.5M to develop bioproducts from proteins
By Jessica Hagen | 01:08 pm | September 11, 2023
The company's computational solution uses AI, modeling and data analysis of naturally occurring proteins to generate superior antibodies, enzymes and vaccine immunogens.